National Health Investors (NYSE:NHI) Posts Earnings Results, Misses Expectations By $0.42 EPS

National Health Investors (NYSE:NHI) posted its earnings results on Tuesday. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42), Zacks reports. The company had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. National Health Investors’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.08 EPS. National Health Investors updated its FY24 guidance to $4.43-$4.44 EPS and its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Stock Performance

NHI stock traded up $2.82 on Thursday, hitting $79.58. The company’s stock had a trading volume of 191,765 shares, compared to its average volume of 193,590. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The stock has a market cap of $3.46 billion, a price-to-earnings ratio of 26.11, a price-to-earnings-growth ratio of 5.05 and a beta of 1.05. National Health Investors has a 1 year low of $49.25 and a 1 year high of $86.13. The firm has a 50 day moving average of $80.38 and a two-hundred day moving average of $73.16.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 4.52%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is 122.45%.

Analyst Upgrades and Downgrades

NHI has been the topic of a number of analyst reports. Wells Fargo & Company downgraded shares of National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price objective for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Bank of America assumed coverage on National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target on the stock. Truist Financial raised their price objective on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Finally, StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.